Long-term evaluation of dabigatran 150 vs. 110 mg twice a day in patients with non-valvular atrial fibrillation
MD Ezekowitz, J Eikelboom, J Oldgren, PA Reilly… - EP …, 2016 - academic.oup.com
Abstract Aims The Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY)
trial allowed patients who completed the trial receiving their assigned dabigatran 150 mg …
trial allowed patients who completed the trial receiving their assigned dabigatran 150 mg …
[HTML][HTML] Long-term evaluation of dabigatran 150 vs. 110 mg twice a day in patients with non-valvular atrial fibrillation
MD Ezekowitz, J Eikelboom, J Oldgren, PA Reilly… - Europace, 2016 - ncbi.nlm.nih.gov
Aims The Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial
allowed patients who completed the trial receiving their assigned dabigatran 150 mg (D150) …
allowed patients who completed the trial receiving their assigned dabigatran 150 mg (D150) …
Long-term evaluation of dabigatran 150 vs. 110 mg twice a day in patients with non-valvular atrial fibrillation
MD Ezekowitz, J Eikelboom, J Oldgren, PA Reilly… - Europace, 2016 - diva-portal.org
Aims The Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial
allowed patients who completed the trial receiving their assigned dabigatran 150 mg (D150) …
allowed patients who completed the trial receiving their assigned dabigatran 150 mg (D150) …
Long-term evaluation of dabigatran 150 vs. 110 mg twice a day in patients with non-valvular atrial fibrillation
MD Ezekowitz, J Eikelboom… - … : journal of the …, 2016 - pubmed.ncbi.nlm.nih.gov
Aims The Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial
allowed patients who completed the trial receiving their assigned dabigatran 150 mg (D150) …
allowed patients who completed the trial receiving their assigned dabigatran 150 mg (D150) …
Long-term evaluation of dabigatran 150 vs. 110 mg twice a day in patients with non-valvular atrial fibrillation.
MD Ezekowitz, J Eikelboom, J Oldgren… - … : Journal of the …, 2016 - europepmc.org
Aims The Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial
allowed patients who completed the trial receiving their assigned dabigatran 150 mg (D150) …
allowed patients who completed the trial receiving their assigned dabigatran 150 mg (D150) …
Long-term evaluation of dabigatran 150 vs. 110 mg twice a day in patients with non-valvular atrial fibrillation.
MD Ezekowitz, J Eikelboom, J Oldgren… - … : Journal of the …, 2016 - europepmc.org
Aims The Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial
allowed patients who completed the trial receiving their assigned dabigatran 150 mg (D150) …
allowed patients who completed the trial receiving their assigned dabigatran 150 mg (D150) …